{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Angiotensinogen", "Diabetes mellitus", "Liver", "M235T", "T174M", "Transplantation"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31497276", "DateRevised": {"Year": "2022", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "2008-6482", "JournalIssue": {"Volume": "10", "Issue": "3", "PubDate": {"Year": "2019"}}, "Title": "International journal of organ transplantation medicine", "ISOAbbreviation": "Int J Organ Transplant Med"}, "ArticleTitle": "Evaluation of Angiotensinogen M235T and T174M Polymorphisms, Demographic and Clinical Factors in New-Onset Diabetes after Liver Transplantation in Iranian Patients.", "Pagination": {"StartPage": "137", "EndPage": "147", "MedlinePgn": "137-147"}, "Abstract": {"AbstractText": ["New-onset diabetes after transplantation (NODAT) is a serious complication which runs the risk of infections, morbidity and mortality.", "To evaluate M235T and T174M polymorphisms of angiotensinogen gene along with some demographic and clinical factors including age; sex; body mass index (BMI); model for end-stage liver disease (MELD) score; prednisolone, mycophenolate mofetil and tacrolimus dose; and serum level in NODAT among liver recipients.", "In this study 115 patients (53 with and 62 without NODAT) who had no history of diabetes before the transplantation were investigated. Furthermore, 80 randomly selected apparently healthy people (no transplantation) were used as the control group. Two angiotensinogen polymorphisms (M235T and T174M) were studied using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP).", "Patients included 68 (59.1%) females and 47 (40.9%) males; they had a mean\u00b1SD age of 37.4\u00b116.9 years. The M allele frequency was 55.7% (n=128) in M235T and 20.0% (n=46) in T174M polymorphisms. Binary logistic regression analysis confirmed that age (p=0.005), prednisolone dose (p<0.001) and mutated M235T polymorphism (p=0.003) were independent risk factors.", "Presence of M235T T allele may significantly (p<0.001) increase the NODAT risk, and increase the likelihood of developing end-stage liver disease (p=0.003). T174M T allele had a significantly (p=0.007) higher frequency in NODAT group."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Mottaghi", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Azarpira", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Dehshahri", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Khalvati", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Namazi", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Int J Organ Transplant Med", "NlmUniqueID": "101535773", "ISSNLinking": "2008-6482"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant. 2004;4:583\u201395.", "ArticleIdList": ["15023151"]}, {"Citation": "Vaughn VM, Cron DC, Terjimanian MN, et al. Analytic morphomics identifies predictors of new-onset diabetes after liver transplantation. Clin Transplant. 2015;29:458\u201364.", "ArticleIdList": ["25740081"]}, {"Citation": "Lee , Sr , Moon JY, Lee SH, et al. Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects. Kidney Blood Press Res. 2013;37:95\u2013102.", "ArticleIdList": ["23594830"]}, {"Citation": "Standards of Medical Care in Diabetes. USA: American Diabetes Association; 2016."}, {"Citation": "Kesiraju S, Paritala P, Rao Ch UM, et al. New onset of diabetes after transplantation - an overview of epidemiology, mechanism of development and diagnosis. Transpl Immunol. 2014;30:52\u20138.", "ArticleIdList": ["24184293"]}, {"Citation": "Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001;59:732\u20137.", "ArticleIdList": ["11168956"]}, {"Citation": "Benson KA, Maxwell AP, McKnight AJ. A HuGE Review and Meta-Analyses of Genetic Associations in New Onset Diabetes after Kidney Transplantation. PLoS One. 2016;11:e0147323.", "ArticleIdList": ["PMC4720424", "26789123"]}, {"Citation": "Van Laecke S, Van Biesen W, Verbeke F, et al. Post transplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. Am J Transplant. 2009;9:2140\u20139.", "ArticleIdList": ["19624560"]}, {"Citation": "Marchetti P. New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transpl. 2005;11:612\u201320.", "ArticleIdList": ["15915488"]}, {"Citation": "Li D-W, Lu T-F, Hua X-W, et al. Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. World J Gastroenterol. 2015;21:6329\u201340.", "ArticleIdList": ["PMC4445111", "26034369"]}, {"Citation": "Musavi Z, Azarpira N, Sangtarash MH, et al. Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation. Int J Organ Transplant Med. 2015;6:14\u201322.", "ArticleIdList": ["PMC4346459", "25737773"]}, {"Citation": "Parvizi Z, Azarpira N, Kohan L, et al. Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation. Mol Biol Rep. 2014;41:6063\u20139.", "ArticleIdList": ["24996284"]}, {"Citation": "Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl. 2007;13:136\u201344.", "ArticleIdList": ["17192854"]}, {"Citation": "Pham P-TT, Pham P-MT, Pham SV, et al. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes. 2011;4:175\u201386.", "ArticleIdList": ["PMC3131798", "21760734"]}, {"Citation": "Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med. 2004;116:263\u201372.", "ArticleIdList": ["14969655"]}, {"Citation": "Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350\u20137.", "ArticleIdList": ["3299096"]}, {"Citation": "Muscogiuri G, Chavez AO, Gastaldelli A, et al. The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. Curr Vasc Pharmacol. 2008;6:301\u201312.", "ArticleIdList": ["18855718"]}, {"Citation": "Kurtz TW, Pravenec M. Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system. J Hypertens. 2004;22:2253\u201361.", "ArticleIdList": ["15614015"]}, {"Citation": "Mateo T, Abu Nabah YN, Abu Taha M, et al. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol. 2006;176:5577\u201386.", "ArticleIdList": ["16622027"]}, {"Citation": "Rossi M, Mennini G, Lai Q, et al. Liver transplantation. J Ultrasound. 2007;10:28\u201345.", "ArticleIdList": ["PMC3478701", "23396075"]}, {"Citation": "QIAmp . DNA Mini and Blood Mini Handbook. In: Qiagen , editor. search resources. 5th ed. Germany : Hilden; 2016 ."}, {"Citation": "Understanding and measuring variations in DNA sample quality: Oxford Gene Technology. 2011.  [(Accessed April 29 2016)].  Available from:  www.ogt.com/resources/literature/483_understanding_and_measuring_variations_in_dna_sample_quality."}, {"Citation": "Basak AA, Sipahi T, Ustundag S, et al. Association of Angiotensinogen T174M and M235T Gene Variants with Development of Hypertension in Turkish Subjects of Trakya Region. Biotechnol & Biotechnol Eq. 2008;22:984\u20139."}, {"Citation": "Kooffreh ME, Anumudu CI, Akpan EE, et al. A study of the M235T variant of the angiotensinogen gene and hypertension in a sample population of Calabar and Uyo, Nigeria. Egypt J Med Hum Genet. 2013;14:13\u20139."}, {"Citation": "Guidelines for PCR Optimization with Taq DNA Polymerase: New England Biolabs\u2122.  [(Accessed May 1 2016) ].  Available from:  www.neb.com/tools-and-resources/usage-guidelines/guidelines-for-pcr-optimization-with-taq-dna-polymerase."}, {"Citation": "Jenkins GJ, Williams GL, Beynon J, et al. Restriction enzymes in the analysis of genetic alterations responsible for cancer progression. Br J Surg. 2002;89:8\u201320.", "ArticleIdList": ["11851658"]}, {"Citation": "Iso H, Harada S, Shimamoto T, et al. Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens. 2000;18:1197\u2013206.", "ArticleIdList": ["10994750"]}, {"Citation": "Tth111I New England Biolabs"}, {"Citation": "Inc. TFS. product information: Thermo Scientific; 2012. Product information NcoI."}, {"Citation": "Chistiakov DA, Turakulov RI, Moiseev VS, et al. Polymorphism of angiotensinogen T174M gene and cardiovascular diseases in the Moscow population. Genetika. 1999;35:1160\u20134.", "ArticleIdList": ["10546120"]}, {"Citation": "Kwitek AE, Olivier M. Genetic Markers and Genotyping Analyses for Genetic Disease Studies Handbook of Pharmaceutical Biotechnology. John Wiley & Sons, Inc; 2006. pp. 661\u201389."}, {"Citation": "Ling Q, Xu X, Xie H, et al. New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry. Liver Int. 2016;35:705\u201312.", "ArticleIdList": ["26681557"]}, {"Citation": "Hornum M, Jorgensen KA, Hansen JM, et al. New onset diabetes mellitus after kidney transplantation in Denmark. Clin J Am Soc Nephrol. 2010;5:709\u201316.", "ArticleIdList": ["PMC2849691", "20167685"]}, {"Citation": "Cho YM, Park KS, Jung HS, et al. High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria. Diabetes Care. 2003;26:1123\u20138.", "ArticleIdList": ["12663584"]}, {"Citation": "Honda M, Asonuma K, Hayashida S, et al. Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients. Clin Transplant. 2013;27:426\u201335.", "ArticleIdList": ["23464510"]}, {"Citation": "Gray N, Picone G, Sloan F, et al. The Relationship between BMI and Onset of Diabetes Mellitus and its Complications. Southern medical journal. 2015;108:29\u201336.", "ArticleIdList": ["PMC4457375", "25580754"]}, {"Citation": "Fagherazzi G, Gusto G, Clavel-Chapelon F, et al. ABO and Rhesus blood groups and risk of type 2 diabetes: evidence from the large E3N cohort study. Diabetologia. 2015;58:519\u201322.", "ArticleIdList": ["25533388"]}, {"Citation": "van Raalte DH. Diabetogenic Effects of Glucocorticoid Drugs: The Knowns and The Unknowns. Amsterdam: Vrije University; 2012."}, {"Citation": "Gomes MB, Cobas RA. Post-transplant diabetes mellitus. Diabetol Metab Syndr. 2009;1:1\u20134.", "ArticleIdList": ["PMC2764563", "19825150"]}, {"Citation": "Gourishankar S, Jhangri GS, Tonelli M, et al. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transplant. 2004;4:1876\u201382.", "ArticleIdList": ["15476489"]}, {"Citation": "Yang J, Hutchinson II, Shah T, et al. Genetic and clinical risk factors of new-onset diabetes after transplantation in Hispanic kidney transplant recipients. Transplantation. 2011;91:1114\u20139.", "ArticleIdList": ["21544032"]}, {"Citation": "Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation. 1997;64:979\u201383.", "ArticleIdList": ["9381545"]}, {"Citation": "Hjelmesaeth J, Hartmann A, Kofstad J, et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant. 2001;16:829\u201335.", "ArticleIdList": ["11274282"]}, {"Citation": "McAlister VC, Haddad E, Renouf E, et al. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant. 2006;6:1578\u201385.", "ArticleIdList": ["16827858"]}, {"Citation": "Xu X, Ling Q, He ZL, et al. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience. Hepatobiliary Pancreat Dis Int. 2008;7:465\u201370.", "ArticleIdList": ["18842490"]}, {"Citation": "Maes BD, Kuypers D, Messiaen T, et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation. 2001;72:1655\u201361.", "ArticleIdList": ["11726827"]}, {"Citation": "Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3:178\u201385.", "ArticleIdList": ["12603213"]}, {"Citation": "Lexi-Comp . Drug Information Handbook: A Clinically Relevant Resource for All Healthcare Professionals. Lexi-Comp, Incorporated: 2014."}, {"Citation": "Staessen JA, Ginocchio G, Wang JG, et al. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovasc Risk. 1997;4:401\u201322.", "ArticleIdList": ["9865673"]}, {"Citation": "Chudek J, Szotowska M, Karkoszka H, et al. Genotypes of renin-angiotensin system and plasma adiponectin concentration in kidney transplant patients. Ann Transplant. 2013;18:593\u2013603.", "ArticleIdList": ["24185422"]}, {"Citation": "Ozdemir BH, Ozdemir FN, Atac FB, et al. Angiotensinogen t235 and angiotensin-converting enzyme insertion/deletion polymorphisms associated with the development of posttransplantation diabetes mellitus in renal allograft recipients. Transplant Proc. 2011;43:572\u20134.", "ArticleIdList": ["21440764"]}, {"Citation": "Farjadian S, Ota M, Inoko H, et al. The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism. Mol Biol Rep. 2009;36:1943\u201350.", "ArticleIdList": ["18979226"]}]}], "History": [{"Year": "2019", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31497276", "PMC6716221"]}}]}